Search results
A condition where the advantages of using the method generally outweigh the theoretical or proven risks: Category 3: A condition where the theoretical or proven risks usually outweigh the advantages of using the method. ... (in breastfeeding or non-breastfeeding women, including post-caesarean section) a) 0 to <48 hours: 1 1: See above: b) 48 ...
The risk of uterine perforation is increased in women who have recently given birth, and in women who are breastfeeding at the time of insertion. In a large US retrospective, postmarketing safety study of IUDs, the risk of uterine perforation was highest when insertion occurred within ≤6 weeks postpartum, and also higher with breastfeeding at ...
a large US retrospective, postmarketing safety study of IUDs, the risk of uterine perforation was highest when insertion occurred within ≤6 weeks postpartum, and also higher with breastfeeding at the time of insertion. The risk of perforation may be increased if Mirena is inserted when the uterus is fixed, retroverted or not completely involuted.
28 lut 2022 · IUD expulsions were analyzed in the full study cohort by postpartum timing interval at insertion and in the subcohort of women with breastfeeding status. We estimated incidence rates, cumulative incidence, and crude and adjusted hazard ratios (HRs) and their 95% CIs for risk of IUD expulsion.
15 cze 2024 · In a small prospective study, forty-six women were randomized to have an IUD containing levonorgestrel (Mirena) inserted either within 10 minutes after placental delivery (n = 15), between 10 minutes and 48 hours after placental delivery (n = 15), or after 6 weeks postpartum (n = 16).
The post-partum subcohort of individuals with breastfeeding information had 673 uterine perforations (62% complete), with a 5-year cumulative incidence of 1·37% (95% CI 1·24–1·52) and an increased risk with breastfeeding (aHR 1·37, 95% CI 1·12–1·66).
8 lis 2021 · The guideline is designed to enable clinicians to support individuals to make informed decisions about choosing and using IUC. It includes information on assessing suitability of IUC use for contraception, the risks and benefits of IUC and guidance for IUC procedures, complications and follow-up.
